Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Online Ordering Portal Signup

By signing up, physicians and delegates can have access to the benefits of Exact Sciences' online ordering portal

Secure and HIPAA compliant portal

Place orders online any time

Assign delegates to place your orders

Obtain results as soon as they become available

Retain all Oncotype DX results in one place

Receive up-to-date announcements on report enhancements

Sign supporting forms and documents for orders

Let's get started. What best describes your role?